Repro Med Systems Inc
NASDAQ:KRMD

Watchlist Manager
Repro Med Systems Inc Logo
Repro Med Systems Inc
NASDAQ:KRMD
Watchlist
Price: 3.81 USD 4.1% Market Closed
Market Cap: 174.7m USD
Have any thoughts about
Repro Med Systems Inc?
Write Note

Repro Med Systems Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Repro Med Systems Inc
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Repro Med Systems Inc
NASDAQ:KRMD
Cash Equivalents
$11.5m
CAGR 3-Years
-25%
CAGR 5-Years
25%
CAGR 10-Years
20%
Becton Dickinson and Co
NYSE:BDX
Cash Equivalents
$1.7B
CAGR 3-Years
-9%
CAGR 5-Years
26%
CAGR 10-Years
-1%
Boston Scientific Corp
NYSE:BSX
Cash Equivalents
$2.5B
CAGR 3-Years
9%
CAGR 5-Years
55%
CAGR 10-Years
26%
Stryker Corp
NYSE:SYK
Cash Equivalents
$3.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Cash Equivalents
$7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash Equivalents
$1.8B
CAGR 3-Years
32%
CAGR 5-Years
23%
CAGR 10-Years
14%
No Stocks Found

Repro Med Systems Inc
Glance View

Market Cap
174m USD
Industry
Health Care

Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Chester New York, New York and currently employs 77 full-time employees. The company is focused on the developing, manufacturing, and commercializing of specialty infusion solutions. The firm's products include the FREEDOM Infusion Systems, which consist of the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgHFlo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The FREEDOM System operates at a lower pressure and maintains a balance between what a patient’s subcutaneous tissues can absorb and what the system delivers. The firm performs product assembly, calibration, pre- and post-assembly quality control inspection and testing, and final packaging for all its products at its Chester, New York facility.

KRMD Intrinsic Value
3.18 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is Repro Med Systems Inc's Cash Equivalents?
Cash Equivalents
11.5m USD

Based on the financial report for Dec 31, 2023, Repro Med Systems Inc's Cash Equivalents amounts to 11.5m USD.

What is Repro Med Systems Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
20%

Over the last year, the Cash Equivalents growth was -34%. The average annual Cash Equivalents growth rates for Repro Med Systems Inc have been -25% over the past three years , 25% over the past five years , and 20% over the past ten years .

Back to Top